Ahmedabad (Gujarat) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Zydus Cadila vaccine (ZycovD) for COVID-19 as a two-dose vaccine for children above the age of 12 years, said Zydus Lifesciences Ltd., the phar
Ahmedabad (Gujarat) [India], March 15 (ANI): Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Colestipol Hydrochloride Tablets in the strength of 1mg (US RLD: Colestid), said the pharmaceutical company on Monday.
New Delhi [India], March 9 (ANI): Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Nitroglycerin Sublingual tablets used to relieve chest pain in people who have certain heart conditions, said the pharmaceutical company
Ahmedabad (Gujarat) [India], March 7 (ANI): Zydus Lifesciences on Monday said it has received approval from the Drug Controller General of India (DCGI) for a new drug application, Oxemia (Desidustat), a first-of-its-kind oral treatment in India for anemia associated with chronic kidney disea
Ahmedabad (Gujarat) [India], February 2 (ANI): Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence
Ahmedabad (Gujarat) [India], November 23 (ANI): Pharmaceutical company Zydus Cadila on Tuesday announced that it has submitted its first "New Drug Application (NDA)" to the Drug Controller General of India for its oral pill "Desidustat" to treat anaemia in kidney patients.
Chennai (Tamil Nadu), November 23 (ANI/BusinessWire India): Zydus Wellness, one of the largest consumer goods companies with power brands like Complan, Sugar Free, Glucon-D, Nycil, Nutralite, Sugarlite, Everyuth, etc has chosen Pando's 10xTMS, a leading Networked-TMS Platform to accelerate t
New Delhi [India], November 18 (ANI): Pharmaceutical company Zydus Cadila will supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA COVID-19 vaccine, to the Government of India by December, government sources said on Thursday.
Ahmedabad (Gujarat) [India], November 10 (ANI): India-based pharma giant, Zydus Cadila received final approval from USFDA for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
Ahmedabad (Gujarat) [India], November 8 (ANI): Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world's first Plasmid DNA COVID-19 vaccine, to the Government of India at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose, excluding G
New Delhi [India], October 28 (ANI): India will procure 30 crore doses of COVID-19 vaccines in November, including six crore doses of Covaxin, 22 crore doses of Covishield and two crore doses of Zydus Cadila's ZyCoV-D, official sources informed ANI on Thursday.
New Delhi [India], October 21 (ANI): As India achieved the milestone of vaccinating over 100 crore citizens on Thursday, we take look at the basket of vaccines developed, manufactured or in use in the country.